Advertisement

Contraception

Published:December 27, 2022DOI:https://doi.org/10.1016/j.mcna.2022.10.005

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Medical Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Finer L.B.
        • Zolna M.R.
        Declines in unintended pregnancy in the United States, 2008-2011.
        N Engl J Med. 2016; 374 (PMID: 26962904; PMCID: PMC4861155): 843-852https://doi.org/10.1056/NEJMsa1506575
        • Allen D.
        • Hunter M.S.
        • Wood S.
        • et al.
        One Key Question®: First Things First in Reproductive Health.
        Matern Child Health J. 2017; 21: 387-392https://doi.org/10.1007/s10995-017-2283-2
        • Song B.
        • White VanGompel E.
        • Wang C.
        • et al.
        Effects of clinic-level implementation of One Key Question® on reproductive health counseling and patient satisfaction.
        Contraception. 2021; 103: 6-12https://doi.org/10.1016/j.contraception.2020.10.018
        • Winner B.
        • Peipert J.F.
        • Zhao Q.
        • et al.
        Effectiveness of long-acting reversible contraception.
        N Engl J Med. 2012; 366: 1998-2007
        • Mestad R.
        • Secura G.
        • Allsworth J.E.
        • et al.
        Acceptance of long-acting reversible contraceptive methods by adolescent participants in the contraceptive CHOICE project.
        Contraception. 2011; 84 (Epub 2011 Apr 27. PMID: 22018123; PMCID: PMC3505875): 493-498https://doi.org/10.1016/j.contraception.2011.03.001
        • American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice
        Committee opinion No. 670: immediate postpartum long-acting reversible contraception.
        Obstet Gynecol. 2016; 128 (PMID: 27454734): e32-e37https://doi.org/10.1097/AOG.0000000000001587
        • Jensen J.T.
        • Lukkari-Lax E.
        • Schulze A.
        • et al.
        Contraceptive efficacy and safety of 52mg LNG-IUS for up to 8 years: findings from the Mirena Extension Trial.
        Am J Obstet Gynecol. 2022; (XX:x.exex.ex [e-pub])https://doi.org/10.1016/j.ajog.2022.09.007
        • Samuelson Bannow B.
        Management of heavy menstrual bleeding on anticoagulation.
        Hematology Am Soc Hematol Educ Program. 2020; 2020 (PMID: 33275699; PMCID: PMC7727540): 533-537https://doi.org/10.1182/hematology.2020000138
        • Hsia J.K.
        • Creinin M.D.
        Intrauterine contraception.
        Semin Reprod Med. 2016; 34: 175-182
        • Spencer A.L.
        • Bonnema R.A.
        • McNamara M.C.
        Helping women choose appropriate hormonal contraception: update on risks, benefits, and indications.
        Am J Med. 2009; 122: 497-506
        • Curtis K.M.
        • Jatlaoui T.C.
        • Tepper N.K.
        • et al.
        U.S. selected practice recommendations for contraceptive use, 2016.
        MMWR Recomm Rep. 2016; 65 (PMID: 27467319): 1-66https://doi.org/10.15585/mmwr.rr6504a1
      1. (Available at:)
        • Dianat S.
        • Fox E.
        • Ahrens K.A.
        • et al.
        Side effects and health benefits of depot medroxyprogesterone acetate: a systematic review.
        Obstet Gynecol. 2019; 133: 332-341https://doi.org/10.1097/AOG.0000000000003089
        • Bonny A.E.
        • Secic M.
        • Cromer B.
        Early weight gain related to later weight gain in adolescents on depot medroxyprogesterone acetate.
        Obstet Gynecol. 2011; 117: 793-797https://doi.org/10.1097/AOG.0b013e31820f387c
        • Lanza L.L.
        • McQuay L.J.
        • Rothman K.J.
        • et al.
        Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture.
        Obstet Gynecol. 2013; 121: 593-600
        • Lee A.
        • Syed Y.Y.
        Estetrol/drospirenone: a review in oral contraception.
        Drugs. 2022; 82 (Epub 2022 Jul 4. [Erratum appears in: Drugs. 2022 Aug;82(12):1341. PMID: 35781795; PMCID: PMC9363382]): 1117-1125https://doi.org/10.1007/s40265-022-01738-8
        • Petitti D.B.
        Combination estrogen-progestin oral contraceptives.
        N Engl J Med. 2003; 349: 1443-1450
        • Parkin L.
        • Sharples K.
        • Hernandez R.K.
        • et al.
        Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case control study based on UK General Practice Research Database.
        BMJ. 2011; 342: d2139https://doi.org/10.1136/bmj.d2139
        • Curtis K.M.
        • Tepper N.K.
        • Jatlaoui T.C.
        • et al.
        U.S. Medical eligibility criteria for contraceptive use.
        MMWR Recomm Rep. 2016; 65: 1-104https://doi.org/10.15585/mmwr.rr6503a1
        • Foran T.
        The management of irregular bleeding in women using contraception.
        Aust Fam Physician. 2017; 46 (PMID: 29036769): 717-720
        • Baker C.C.
        • Chen M.J.
        New contraception update - Annovera, Phexxi, Slynd, and Twirla.
        Curr Obstet Gynecol Rep. 2022; 11 (Epub 2022 Jan 6. PMID: 35795653; PMCID: PMC9255890): 21-27https://doi.org/10.1007/s13669-021-00321-4
        • Trussell J.
        • Aiken A.R.A.
        • Micks E.
        • et al.
        Efficacy, safety, and personal considerations.
        in: Hatcher R.A. Nelson A.L. Trussell J. Contraceptive technology. 21st edition. Ayer Company Publishers, Inc., New York2018
      2. Practice bulletin No. 152: emergency contraception.
        Obstet Gynecol. 2015; 126 (PMID: 26287787): e1-e11https://doi.org/10.1097/AOG.0000000000001047
        • Turok D.K.
        • Gero A.
        • Simmons R.G.
        • et al.
        Levonorgestrel vs. copper intrauterine devices for emergency contraception.
        N Engl J Med. 2021; 384 (PMID: 33503342; PMCID: PMC7983017): 335-344https://doi.org/10.1056/NEJMoa2022141